This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

  1. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  2. Corresponding Author: Austin M. Spitz, MS, Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, 2000 Levy Ave St 0337, Tallahassee, FL 32306 ([email protected]).
  3. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  4. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  5. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  6. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  7. Department of Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, Florida
  1. American Psychological Association. APA Dictionary of Psychology. American Psychological Association. Accessed Februrary 9, 2023. https://dictionary.apa.org/dysphoria
  2. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–2445. PubMed CrossRef
  3. Tiller JWG. Depression and anxiety. Med J Aust. 2013;199(S6):S28–S31. PubMed CrossRef
  4. Fishbain DA, Pulikal A, Lewis JE, et al. Chronic Pain types Differ in their reported prevalence of post-traumatic stress disorder (PTSD) and there is consistent evidence that chronic pain is associated with PTSD: an evidence-based structured systematic review. Pain Med. 2017;18(4):711–735. PubMed CrossRef
  5. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–1917. PubMed CrossRef
  6. Tunvirachaisakul C, Gould RL, Coulson MC, et al. Predictors of treatment outcome in depression in later life: a systematic review and meta-analysis. J Affect Disord. 2018;227:164–182. PubMed CrossRef
  7. Cavicchioli FL, Maes M, Roomruangwong C, et al. Associations between severity of anxiety and clinical and biological features of major affective disorders. Psychiatry Res. 2018;260:17–23. PubMed CrossRef
  8. Steiner AJ, Boulos N, Mirocha J, et al. Quality of life and functioning in comorbid posttraumatic stress disorder and major depressive disorder after treatment with citalopram monotherapy. Clin Neuropharmacol. 2017;40(1):16–23. PubMed
  9. Cunningham NR, Jagpal A, Tran ST, et al. Anxiety adversely impacts response to cognitive behavioral therapy in children with chronic pain. J Pediatr. 2016;171:227–233. PubMed CrossRef
  10. Bair MJ, Poleshuck EL, Wu J, et al. Anxiety but not social stressors predict 12- month depression and pain severity. Clin J Pain. 2013;29(2):95–101. PubMed CrossRef
  11. Sundermann EE, Tang B, Kim M, et al. Neuropsychiatric predictors of cognitive functioning over a one-year follow-up period in HIV. J Affect Disord. 2023;336:92–96. PubMed
  12. Passos GS, Youngstedt SD, Rozales AARC, et al. Insomnia severity is associated with morning cortisol and psychological health. Sleep Sci. 2023;16(1):92–96. PubMed
  13. Saveanu R, Etkin A, Duchemin AM, et al. The International Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. J Psychiatr Res. 2015;61:1–12. PubMed CrossRef
  14. Xu J, Fregni F, Brody AL, et al. Transcranial direct current stimulation reduces negative affect but not cigarette craving in overnight abstinent smokers. Front Psychiatry. 2013;4:112. PubMed CrossRef
  15. Roh HT, So WY. Cranial electrotherapy stimulation affects mood state but not levels of peripheral neurotrophic factors or hypothalamic– pituitary–adrenal axis regulation. Technol Health Care. 2017;25(3):403–412. PubMed CrossRef
  16. Senda MC, Johnson KA, Taylor IM, et al. A pilot trial of stepwise implementation of virtual reality mindfulness and accelerated transcranial magnetic stimulation treatments for dysphoria in neuropsychiatric disorders. Depress Anxiety. 2023;2023:1–16.
  17. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389. PubMed CrossRef
  18. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. PubMed CrossRef
  19. Weathers FW, Bovin MJ, Lee DJ, et al. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383–395. PubMed CrossRef
  20. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 suppl 1):S22–S31. PubMed CrossRef
  21. McNair DM, Lorr M, Droppleman LF. Profile of mood states. Educational and Industrial Testing Service; 1971.
  22. Comotto S, Bottoni A, Moci E, et al. Analysis of session-RPE and profile of mood states during a triathlon training camp. J Sports Med Phys Fitness. 2015;55(4):361–367. PubMed
  23. Hoffman CJ, Ersser SJ, Hopkinson JB, et al. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol. 2012;30(12):1335–1342. PubMed CrossRef
  24. Meyer JD, Koltyn KF, Stegner AJ, et al. Influence of exercise intensity for improving depressed mood in depression: a dose-response study. Behav Ther. 2016;47(4):527–537. PubMed CrossRef
  25. McNair DM, Heuchert JWP, Shilony E. Profile of Mood States manual: Bibliography 1964–2002. Multi- Health Systems Inc; 2003.
  26. Grove JR, Prapavessis H. Preliminary evidence for the reliability and validity of an abbreviated Profile of Mood States. Int J Sport Psychol. 1992;23(2):93–109.
  27. Curran SL, Andrykowski MA, Studts JL. Short Form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess. 1995;7(1):80–83.
  28. Tobin R, Dunkley DM. Self-critical perfectionism and lower mindfulness and self compassion predict anxious and depressive symptoms over two years. Behav Res Ther. 2021;136:103780. PubMed CrossRef
  29. Vujanovic AA, Zvolensky MJ, Bernstein A, et al. A test of the interactive effects of anxiety sensitivity and mindfulness in the prediction of anxious arousal, agoraphobic cognitions, and body vigilance. Behav Res Ther. 2007;45(6):1393–1400. PubMed CrossRef
  30. Zvolensky MJ, Bakhshaie J, Garza M, et al. Anxiety sensitivity and mindful attention in terms of anxiety and depressive symptoms and disorders among Latinos in primary care. Psychiatry Res. 2015;229(1–2):245–251. PubMed CrossRef
  31. Fava M, Uebelacker LA, Alpert JE, et al. Major depressive subtypes and treatment response. Biol Psychiatry. 1997;42(7):568–576. PubMed CrossRef
  32. Hernandez MJ, Reljic T, Van Trees K, et al. Impact of comorbid PTSD on outcome of repetitive Transcranial Magnetic Stimulation (TMS) for veterans with depression. J Clin Psychiatry. 2020;81(4):19m13152. PubMed CrossRef
  33. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2):522–534. PubMed CrossRef
  34. Clarke E, Clarke P, Gill S, et al. Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders. J Affect Disord. 2019;252:435–439. PubMed CrossRef
  35. Philip NS, Leuchter AF, Cook IA, et al. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depress Anxiety. 2019;36(3):278–285. PubMed CrossRef
  36. Hutton TM, Aaronson ST, Carpenter LL, et al. The anxiolytic and antidepressant effects of transcranial magnetic stimulation in patients with anxious depression. J Clin Psychiatry. 2023;84(1):22m14571. PubMed CrossRef
  37. Senda MC, Johnson, KA, Taylor, IM, et al. A pilot trial of stepwise implementation of virtual reality mindfulness and accelerated transcranial magnetic stimulation treatments for dysphoria in neuropsychiatric disorders. Depress Anxiety. Forthcoming 2023.
  38. Fitzsimmons SMDD, van der Werf YD, van Campen AD, et al. Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: a systematic review and pairwise/network meta-analysis. J Affect Disord. 2022;302:302–312. PubMed
  39. Parikh TK, Strawn JR, Walkup JT, et al. Repetitive transcranial magnetic stimulation for generalized anxiety disorder: a systematic literature review and meta-analysis. Int J Neuropsychopharmacol. 2022;25(2):144–146. PubMed CrossRef
  40. Cirillo P, Gold AK, Nardi AE, et al. Transcranial magnetic stimulation in anxiety and trauma-related disorders: a systematic review and meta-analysis. Brain Behav. 2019;9(6):e01284. PubMed CrossRef
  41. Siddiqi SH, Taylor SF, Cooke D, et al. Distinct symptom-specific treatment targets for circuit-based neuromodulation. Am J Psychiatry. 2020;177(5):435–446. PubMed CrossRef